Showing results (1-10 of 62) with videos related to
Sort By:
Pageof 7
Cancer Immunology, Immunotherapy : CII|March 5, 2008
HLA typing demands for peptide-based anti-cancer vaccineDirk Nagorsen, Eckhard ThielClinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2006
Clinical and immunologic responses to active specific cancer vaccines in human colorectal cancerDirk Nagorsen, Eckhard ThielCurrent Opinion in Investigational Drugs (London, England : 2000)|December 7, 2007
Monoclonal antibodies in clinical hematology and oncologyDirk Nagorsen, Eckhard ThielExperimental Cell Research|March 23, 2011
Immunomodulatory therapy of cancer with T cell-engaging BiTE antibody blinatumomabDirk Nagorsen, Patrick A BaeuerleIn Vivo (Athens, Greece)|December 24, 2002
How to analyze ex vivo T-cell responses in cancer patientsDirk Nagorsen, Francesco M MarincolaExpert Opinion on Biological Therapy|May 15, 2015
Utilizing the BiTE (bispecific T-cell engager) platform for immunotherapy of cancerJulia Stieglmaier, Jonathan Benjamin, Dirk NagorsenInternational Immunology|September 21, 2014
Unleashing the clinical power of T cells: CD19/CD3 bi-specific T cell engager (BiTE®) antibody construct blinatumomab as a potential therapyZachary Zimmerman, Tapan Maniar, Dirk NagorsenCytokine|December 23, 2003
Cytokine and chemokine expression profiles of maturing dendritic cells using multiprotein platform arraysDirk Nagorsen, Francesco M Marincola, Monica C PanelliExpert Opinion on Biological Therapy|October 6, 2004
Immunological monitoring of cancer vaccine therapyDirk Nagorsen, Carmen Scheibenbogen, Eckhard Thiel, et al.In Vivo (Athens, Greece)|December 24, 2002
Bacteria-related spontaneous and therapeutic remission of human malignanciesDirk Nagorsen, Francesco M Marincola, Hans E KaiserPageof 7